TickerHumNYSE · Healthcare · Medical Devices
Medtronic plc (MDT)
As of Sep 28, 3:20 PM ET, Medtronic (MDT) last traded at $88.69, up 0.06% on the day. Its TickerHum research score is 61/100 (above average). It reported revenue of $37.54B for the twelve months ending 2026-07-31, up 9.8% year over year, with a 18.1% operating margin.
Ratings
- Valuation: 80/100 — Strongest input: price / sales (ttm) 3.0x. Weakest: free-cash-flow yield 5.4 %.
- Growth: 52/100 — Strongest input: diluted eps growth (ttm, yoy) +12.2 %. Weakest: revenue growth (ttm, yoy) +9.8 %.
- Profitability: 61/100 — Strongest input: gross margin 55.7 %. Weakest: return on equity 10.4 %.
- Financial health: 53/100 — Strongest input: long-term debt / equity 0.51. Weakest: cash / long-term debt 0.07.
- Momentum: 49/100 — Strongest input: 3-month return +9.6 %. Weakest: 1-year return -5.6 %.
- Attention: 86/100 — Strongest input: headlines in the last 7 days 17. Weakest: volume vs 3-month average 2.3x.
- Risk: 71/100 — Strongest input: annualised volatility (1y) 23.6 %. Weakest: max drawdown (1y) -30.0 %.
- Data confidence: 100/100 — Based on inputs available 100 %, quote age (hours) 0 h, latest financial period age (days) 32 d.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $37.54B | TTM ending 2026-07-31 · 10-Q |
| Revenue growth | 9.8% | TTM ending 2026-07-31 · 10-Q |
| Net income | $5.23B | TTM ending 2026-07-31 · 10-Q |
| Diluted EPS | $4.06 | TTM ending 2026-07-31 · 10-Q |
| Gross margin | 55.7% | FY ending 2018-04-27 · 10-K |
| Operating margin | 18.1% | TTM ending 2026-07-31 · 10-Q |
| Net margin | 13.9% | TTM ending 2026-07-31 · 10-Q |
| Free cash flow | $6.13B | TTM ending 2026-07-31 · 10-Q |
| Cash | $1.69B | as of 2026-07-31 · 10-Q |
| Long-term debt | $25.62B | as of 2026-07-31 · 10-Q |
| Debt / equity | 0.51 | as of 2026-07-31 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0001613103).
Compare Medtronic with its closest competitors
- Medtronic vs Boston Scientific (MDT vs BSX) — Same industry (Medical Devices); market cap 0.56x; shares: cardiology, medical devices
- Medtronic vs Stryker (MDT vs SYK) — Same industry (Medical Devices); market cap 0.93x; shares: medical devices
- Medtronic vs Abbott Laboratories (MDT vs ABT) — Same industry (Medical Devices); market cap 1.6x; shares: medical devices
- Medtronic vs Edwards Lifesciences (MDT vs EW) — Same industry (Medical Devices); market cap 0.44x; shares: cardiology
- Medtronic vs Bristol-Myers Squibb (MDT vs BMY) — Same sector (Healthcare), different industry; market cap 1.1x
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.